Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2871 of 5804
-
Can extra Check-Ups after stroke or heart attack save lives and money?
Disease control CompletedCerebral Vascular Accidents (stroke) and Myocardial Infarction (MI), which share the same risk factors, treatments and pathophysiological mechanisms, have become two major public health problems due to the increase in their prevalence rate and the longer survival after such an ev…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Your phone could help beat depression: new app trial launches
Symptom relief Recruiting nowTesting and validating an e-health (smartphone application) approach to better understand the determinants of day-to-day symptomatology in depression, medication adherence, and treatment efficacy in the goal of maximizing patient care.
Phase: NA • Sponsor: Centre Hospitalier Charles Perrens, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Heart surgery bowel breakthrough? drug may speed recovery
Symptom relief CompletedPostoperative ileus, defined as the transient postoperative functional inhibition of propulsive bowel activity, commonly occurs in patients after cardiac surgery and contributes to postoperative morbidity. Naloxegol is a peripheral opioid receptor antagonist. Recent studies show…
Phase: PHASE3 • Sponsor: CMC Ambroise Paré • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Soft cast could ease healing of diabetic foot sores
Disease control Recruiting nowTo determine the effectiveness, compliance, patient tolerance, ease of use and safety of total contact soft cast in diabetic foot ulcers.
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New antibody shows promise for blistering skin disease
Disease control CompletedThe development of Auto Immune bullous Diseases (AIBD) results from a complex interaction between innate and adaptive immune systems. Bullous pemphigoid (BP), the most frequently encountered AIBD, predominantly affects elderly patients above 70 with an estimated incidence of 21.7…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Bone drug breakthrough: could less be more for cancer patients?
Symptom relief OngoingThe investigators propose to perform a pragmatic, multicenter, open-label, randomised clinical trial to demonstrate the efficacy and safety of either continuing or further de-escalating BMA after a minimum of two years of BMA treatment in patients with bone metastases from breast…
Phase: PHASE4 • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New hope for Hard-to-Treat cancers?
Disease control OngoingThe purpose of this study is to assess the safety and tolerability of DS-1055a in participants with relapsed or refractory locally advanced or metastatic solid tumors for which no standard treatment is available.
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Exercise tailored to boost heart health in breast cancer survivors
Symptom relief Recruiting nowThis study will compare the effects on cardiorespiratory fitness (CRF) of aerobic exercise in different amounts (number of minutes/session) over different periods of time (number of weeks). Aerobic exercise is physical activity of light-to-moderate intensity that uses the large m…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Lung cancer maintenance combo trial stopped early
Disease control TerminatedThe purpose of the study is to determine whether adding vorolanib to atezolizumab will improve the length of time that participants are cancer-free after receiving standard chemotherapy.
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Canadian study checks how well RA drug works in daily life
Disease control CompletedRheumatoid Arthritis (RA) is an inflammatory disease of the joints causing pain, stiffness, swelling and loss of joint function. This study will assess how effective Upadacitinib is in changing the disease symptoms in Canadian participants with RA. Upadacitinib is a drug approve…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 26, 2026 12:41 UTC
-
Can a simple blood test predict cancer return? new study investigates
Knowledge-focused Recruiting nowThis is a research study for individuals who have cancer associated with human papillomavirus (HPV) and are being treated with radiation as part of standard care for their cancer. Doctors leading this study will use blood tests to find out if they can detect the HPV virus in the …
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New combo therapy targets tough lung cancer
Disease control Recruiting nowThis is a phase I, dose escalating study evaluating the safety of combining talazoparib and low dose consolidative thoracic radiotherapy for small cell lung cancer patients. This study will also determine the maximum tolerated dose (MTD) of talazoparib in combination with low dos…
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Ofev under the microscope: Real-World safety data for lung disease patients
Disease control CompletedThe primary objective is to evaluate the incidence of adverse drug reactions (focus on hepatic function disorders) of Ofev Capsules under the real world setting in patients with Chronic fibrosing Interstitial Lung Diseases with a progressive phenotype (PF-ILD).
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a quicker infusion tame tough gout?
Disease control CompletedThe purpose of this study is to assess the safety, tolerability and efficiency of pegloticase administered with a shorter infusion duration in participants with uncontrolled gout receiving methotrexate.
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can a home exercise program help liver transplant patients get stronger?
Symptom relief CompletedFrailty is a significant problem in patients undergoing liver transplant and is associated with poor outcomes and survival. Hence, optimizing physical fitness and counteracting frailty is important. However, many interventions are very resource intensive and therefore not feasibl…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Can a common arthritis drug tame CAR-T's dangerous side effects?
Symptom relief CompletedThis research study is studying the combination of anakinra and axicabtagene ciloleucel to reduce the occurrence of the side effects Cytokine Release Syndrome (CRS) and neurologic toxicities with relapsed or refractory Non-Hodgkin lymphoma (NHL). * Relapsed NHL is the condition …
Phase: PHASE2 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Heart drug may limit scarring after attack
Disease control CompletedTrimetazidine is a agent promoting glucose utilization by limiting fatty-acid oxidation.Trimetazidine could improve cardiac function in patients with ischemic heart disease. We aimed to explore effect of Trimetazidine on final myocardial fibrosis for patients with ST-elevation my…
Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
NMN supplement shows promise for prediabetes in early human test
Disease control CompletedThe goal of this proposal is to determine whether the beneficial effects of NMN on metabolic function observed in rodents applies to people.
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Protein-Packed diet may help kids fight obesity and diabetes risk
Disease control OngoingThe main purpose of the present study is to perform a 10 weeks dietary intervention study with a follow-up for 52 weeks in children from 7-14 years of age with overweight or obesity. In a caloric restricted and increased physical activity setting the control group will consume a …
Phase: NA • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a skin cancer drug reboot chemo for tough breast tumors?
Disease control CompletedTriple-negative breast cancer (TNBC) is biologically aggressive and has limited systemic treatment options, often compounded by treatment resistance. Cell state transitions, e.g. epithelial-to-mesenchymal transition (EMT) govern cancer cell behaviour. The investigators hypothes…
Phase: PHASE1 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC